Advanced imaging to detect early pancreatic cancer during surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a special high-resolution camera that can see tiny details during pancreatic surgery to help doctors detect early-stage pancreatic cancer or precancerous growths called IPMNs. The goal is to improve how well surgeons can identify and remove diseased tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have pancreatic cancer or IPMN (a growth in the pancreas that may become cancer)
- You are scheduled to have surgery to remove part or all of your pancreas
- You are able to give informed consent to participate
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
This trial uses advanced imaging to detect pancreatic cancer early and track how well treatment is working. It may help if you have pancreatic cancer that can be surgically removed, either right away or after chemotherapy.
This trial tests whether a targeted antibody with a fluorescent dye can help surgeons see and remove pancreatic cancer during planned surgery. It’s an early-phase study, so the main goal is to see if the approach is safe and useful around the time of the operation.
This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.
This trial uses a special ultrasound technique (Superb Microvascular Imaging) to better understand the material inside a type of pancreatic cyst called a PIMPT. It may help doctors decide if the cyst is dangerous without needing more invasive tests.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
Hear when a new Pancreatic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.